Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
NCT05740683 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-10-02
Summary
Test of early warning signs and RT-QuIC in patients with idiopathic olfactory dysfunction
Conditions
- Idiopathic Anosmia
- Idiopathic Hyposmia
- Idiopathic Olfactory Dysfunction
Interventions
- DIAGNOSTIC_TEST
-
RT-QuiC
RT-QuIC measures the ability of aSyn to misfold other aSyn proteins and is an amplification technique.
Sponsors & Collaborators
-
Danish Reference Center for Prion Diseases, Rigshospitalet
collaborator UNKNOWN -
Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet
collaborator UNKNOWN -
Danish Dementia Research Centre
lead NETWORK
Principal Investigators
-
Kristian S Frederiksen · Danish Dementia Research Centre, Rigshospitalet, Capital Region
-
Oskar McWilliam · Danish Dementia Research Centre, Rigshospitalet, Capital Region
-
Steen G Hasselbalch · Danish Dementia Research Centre, Rigshospitalet, Capital Region
-
Gunhild Waldemar · Danish Dementia Research Centre, Rigshospitalet, Capital Region
-
Marie Brunn · Danish Dementia Research Centre, Rigshospitalet, Capital Region
-
Anja H Simmonsen · Danish Dementia Research Centre, Rigshospitalet, Capital Region
Eligibility
- Min Age
- 55 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2032-12-31
- Completion
- 2032-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil
NCT01845636 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease
NCT04445831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A
NCT01568086 ·Status: TERMINATED
-
Olfactory Neuroepithelial Tissue of Alzheimer Disease
NCT02129452 ·Status: COMPLETED
-
Identifying Potential Effects of Liraglutide on Degenerative Changes
NCT01469351 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
NCT06995573 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Open-Label Extension Protocol to SNK01-AD01 Study
NCT07228078 ·Status: RECRUITING ·Phase: PHASE2
-
Memory and Insulin in Early Alzheimer's Disease
NCT00581867 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
NCT01357629 ·Status: TERMINATED
-
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
NCT03806478 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)
NCT03668405 ·Status: TERMINATED ·Phase: PHASE1
-
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
NCT01951118 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
NCT01238991 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
NCT00422981 ·Status: COMPLETED ·Phase: PHASE2
-
Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease
NCT04749563 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
NCT05469360 ·Status: RECRUITING ·Phase: PHASE1
-
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
NCT05522387 ·Status: TERMINATED ·Phase: PHASE2
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352 ·Status: RECRUITING ·Phase: PHASE3
-
Long-term Safety and Tolerability of AFFITOPE AD01
NCT00711139 ·Status: COMPLETED
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
NCT01841905 ·Status: UNKNOWN
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Nasal Protollin in Early Symptomatic Alzheimer's Disease
NCT07187141 ·Status: COMPLETED ·Phase: PHASE1
-
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
NCT04937959 ·Status: UNKNOWN